JP2023521150A5 - - Google Patents

Info

Publication number
JP2023521150A5
JP2023521150A5 JP2022561651A JP2022561651A JP2023521150A5 JP 2023521150 A5 JP2023521150 A5 JP 2023521150A5 JP 2022561651 A JP2022561651 A JP 2022561651A JP 2022561651 A JP2022561651 A JP 2022561651A JP 2023521150 A5 JP2023521150 A5 JP 2023521150A5
Authority
JP
Japan
Prior art keywords
silver nanoparticles
use according
nanoparticles
suspension
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521150A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025942 external-priority patent/WO2021207178A1/en
Publication of JP2023521150A publication Critical patent/JP2023521150A/ja
Publication of JP2023521150A5 publication Critical patent/JP2023521150A5/ja
Pending legal-status Critical Current

Links

JP2022561651A 2020-04-06 2021-04-06 コロナウイルス感染の阻害および処置に使用するための銀ナノ粒子 Pending JP2023521150A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063005727P 2020-04-06 2020-04-06
US63/005,727 2020-04-06
PCT/US2021/025942 WO2021207178A1 (en) 2020-04-06 2021-04-06 Silver nanoparticles for use in inhibiting and treating coronavirus infection

Publications (2)

Publication Number Publication Date
JP2023521150A JP2023521150A (ja) 2023-05-23
JP2023521150A5 true JP2023521150A5 (enExample) 2024-04-17

Family

ID=78023543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561651A Pending JP2023521150A (ja) 2020-04-06 2021-04-06 コロナウイルス感染の阻害および処置に使用するための銀ナノ粒子

Country Status (5)

Country Link
US (1) US20230158067A1 (enExample)
EP (1) EP4132467A4 (enExample)
JP (1) JP2023521150A (enExample)
CN (1) CN115551482A (enExample)
WO (1) WO2021207178A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202412860A (zh) * 2022-05-30 2024-04-01 日商信越化學工業股份有限公司 抗病毒性組成物及於表面具有該組成物的構件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135195B2 (en) * 1999-06-01 2006-11-14 American Silver, Llc Treatment of humans with colloidal silver composition
US20070026087A1 (en) * 2003-10-16 2007-02-01 Toagosei Co., Ltd. Anti-coronavirus agent
KR20050077887A (ko) * 2004-01-28 2005-08-04 (주)지피엔이 코로나 바이러스 및 인플루엔자 바이러스 등에 억제능이있는 나노무기항균제
JP2008523063A (ja) * 2004-12-06 2008-07-03 ノヴァセントリックス コープ 金属ナノ材料組成の抗ウィルス使用法
US20130315972A1 (en) * 2012-05-24 2013-11-28 Agienic, Inc. Compositions and methods for antimicrobial metal nanoparticles
WO2012174466A2 (en) * 2011-06-17 2012-12-20 Annuary Healthcare, Inc. Nanoscale particle formulations and methods
CN102579490A (zh) * 2012-02-22 2012-07-18 大连大学 一种纳米银抗病毒溶液及其制作方法
CN102861102A (zh) * 2012-09-21 2013-01-09 华绣科技有限公司 一种纳米银抑菌喷剂
US20160081346A1 (en) * 2014-09-23 2016-03-24 Attostat, Inc. Antimicrobial compositions and methods
US9839652B2 (en) * 2015-04-01 2017-12-12 Attostat, Inc. Nanoparticle compositions and methods for treating or preventing tissue infections and diseases
CN105412379A (zh) * 2015-12-09 2016-03-23 刘传新 一种吸入式治疗肺结核制剂及其制备方法
SI25804A (sl) * 2020-03-19 2020-09-30 Danijela Marković Koloidno srebro za uporabo in postopek njegove priprave

Similar Documents

Publication Publication Date Title
US10342820B2 (en) Antiviral composition comprising a sulfated polysaccharide
CN109310622A (zh) 尼古丁颗粒和组合物
JP2017502064A5 (enExample)
WO2005074990A2 (en) Methods of preventing and treating sars using low ph respiratory tract compositions
JP2007513959A5 (enExample)
ES2303645T3 (es) Composiciones para prevenir y tratar sintomas de tipo resfriado y gripe que comprenden cinc quelado.
NZ518117A (en) Respiratory tract compositioning pyroglutamic acid and an organic acid for application to the nasal tissues
ITMI20101459A1 (it) Composizione comprendente glutatione reduttasi e glutatione ossidato
EP1583559B1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
EP2249866A2 (de) Verwendung eines acetylsalicylsäuresalzes zur behandlung viraler infektionen
JP2013515022A (ja) 相乗的抗ウイルス組成物及びその使用
WO2007011396A3 (en) Particles for treatment of pulmonary infection
HRP20211810T1 (hr) Liječenje i prevencija prehlade korištenjem povidon-joda
JP2023521150A5 (enExample)
HRP20120286T1 (hr) Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti
CN113750052B (zh) 一种乙酰半胱氨酸颗粒及其制备方法
JP2023521150A (ja) コロナウイルス感染の阻害および処置に使用するための銀ナノ粒子
WO2021158851A1 (en) Pharmaceutical formulation containing remdesivir
US20220401472A1 (en) Compositions for prevention and treatment of rsv and coronavirus infection
CN101022797B (zh) 具有2-咪唑啉结构的α-拟交感神经药的新用途
JPH09227373A (ja) 抗インフルエンザウイルス剤
AU2022410715B2 (en) Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2
JP2002030000A (ja) 風邪根本治療法
JP2024547022A5 (enExample)
HK40086332A (zh) 用於抑制和治疗冠状病毒感染的银纳米颗粒